Miller School of Medicine could one day change the way people with atrial fibrillation are treated. Researchers at UM ...
The appointment gives a former Abbott leader oversight of efforts to bring a pulsed field ablation device to market.
Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST) a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced details on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results